Sarissa Capital Management acquired a 6.22% ownership stake in biotechnology firm Ariad Pharmaceuticals.
Ariad Pharmaceuticals Inc
Breaking News
- US Secretary of State Antony Blinken Calls on China to Treat American Companies Fairly During Visit to Shanghai
- HYBE Files Police Report Against NewJeans Label CEO Min Hee-Jin Amid ADOR Exec's Emotional Press Conference
- Minneapolis City Council Unanimously Approves Minimum Retail Price of $15/Pack for Cigarettes to Improve Public Health
Subscribe to VCpost newsletter
Most Popular
- SSI Payment for May 2024: Supplemental Security Income Recipients to See Double Amount in Payout
- Doctors Raise Concerns Over Proposed Capital Gains Tax Changes
- How to Apply for Social Security Spousal Benefits; Here's How You May Boost Your Money!
- How to Get IRS Unclaimed Tax Refunds: Here's What to Do If You Think You Have Pending Payments
- JPMorgan CEO Warns of Economic Risks Amid Biden's 'Huge' Deficit Spending, Questions Likelihood of 'Soft Landing'
- MSC Darwin Ship Targeted by Yemen's Houthis in Gulf of Aden
- Google's Parent Company Alphabet Approves First-Ever Dividend as Shares Skyrocket
- Norway Airspace Shuts Down for Several Hours Following Technical Glitch
